Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors
Clinical trial NCT02703571 · TERMINATED
Trial details
- NCT number
- NCT02703571
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-29
- Primary completion
- 2019-09-24
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.